Obama calls for major new personalized medicine initiative

Published 01/20/2015, 10:04 PM
Updated 01/20/2015, 10:10 PM
© Reuters. U.S. President Barack Obama delivers his State of the Union address to a joint session of the U.S. Congress on Capitol Hill in Washington

WASHINGTON (Reuters) - President Barack Obama said in his State of the Union speech on Tuesday that his administration wants to launch a new push to use personalized genetic information to help treat diseases like cancer and diabetes.

Obama urged Congress in his address to boost research funding to support new investments in "precision medicine." "I want the country that eliminated polio and mapped the human genome to lead a new era of medicine – one that delivers the right treatment at the right time," Obama said, noting the approach had helped reverse cystic fibrosis in some patients.

"Tonight, I'm launching a new precision medicine initiative to bring us closer to curing diseases like cancer and diabetes – and to give all of us access to the personalized information we need to keep ourselves and our families healthier."

The sequencing of individual genomes, read-outs of a person's complete genetic information, could speed scientific research and help drug companies and physicians tailor medicines to an individual's genetic profile.

Using genomic data to identify which patients will benefit could save tens of billions of dollars now spent on ineffective drugs.

© Reuters. U.S. President Barack Obama delivers his State of the Union address to a joint session of the U.S. Congress on Capitol Hill in Washington

Obama's call follows a move announced last year in England under which a company owned by the Department of Health aimed to sequence 100,000 whole genomes from National Health Service patients by 2017.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.